Sofinnova is a clinical-stage biopharmaceutical venture capital firm that deploys human and financial capital to turn dreams into drugs. With approximately $2B in assets under management and committed capital, the company partners with world-class entrepreneurs to challenge the status quo of medical care, advance cures, and improve lives.
No recent news for this company.